Lansdowne Partners (Uk) LLP Pure Tech Health PLC Transaction History
Lansdowne Partners (Uk) LLP
- $937 Million
- Q3 2025
Shares
1 transactions
Others Institutions Holding PRTC
# of Institutions
7Shares Held
102KCall Options Held
0Put Options Held
0-
Pentwater Capital Management LP Naples, FL75KShares$1.21 Million0.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny17.8KShares$288,3100.0% of portfolio
-
Diadema Partners LP Morristown, NJ7.32KShares$118,3550.03% of portfolio
-
Persistent Asset Partners LTD Hong Kong, K31.69KShares$27,2290.02% of portfolio
-
Ubs Group Ag20Shares$3230.0% of portfolio
About PureTech Health plc
- Ticker PRTC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,888,500
- Market Cap $451M
- Description
- PureTech Health plc, a clinical-stage biotherapeutics company, discovers, develops, and commercializes medicines for inflammatory, fibrotic and immunological, intractable cancers, lymphatic and gastrointestinal, neurological and neuropsychological, and other diseases in the United States. The company offers KarXT targeting muscarinic acetylcholi...